Approvals/TGA/RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 4.5 mg capsule blister pack

Approved

STANDARD

RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 4.5 mg capsule blister pack

Dr Reddys Laboratories Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8a47ea5a4bcd4bde
Product Name: RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 4.5 mg capsule blister pack
Artg Id: 177407
Artg Name: RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 4.5 mg capsule blister pack
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path: /organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date: 2012-09-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8a47ea5a4bcd4bde

Type

Standard